Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1703035

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1703035

Cancer Insurance Global Market Report 2025

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Cancer insurance is an additional form of health coverage designed to assist with expenses arising from the diagnosis and treatment of cancer that go beyond what regular health insurance typically covers. This can encompass medical treatments, non-medical costs, income loss during treatment, and other related expenditures.

There are several types of cancer insurance, such as lung cancer and liver cancer coverage. Lung cancer insurance targets individuals specifically concerned about the risks associated with lung cancer, offering financial assistance for medical treatments, care, and associated expenses related to lung cancer diagnosis and treatment. These insurance plans are classified into individual plans, supplement plans, and critical illness plans. Distribution channels include brokers, bancassurance, agents, direct sales, and others, while the end users encompass both adults and children.

The cancer insurance market research report is one of a series of new reports from the business research company that provides cancer insurance market statistics, including cancer insurance industry global market size, regional shares, competitors with an cancer insurance market share, detailed cancer insurance market segments, market trends and opportunities, and any further data you may need to thrive in the cancer insurance industry. This cancer insurance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer insurance market size has grown strongly in recent years. It will grow from $75.67 billion in 2024 to $82.01 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing cancer incidence rates, medical inflation, awareness and education, and a potential rise in premiums reflecting increased treatment costs, economic growth, government policies, and support.

The cancer insurance market size is expected to see strong growth in the next few years. It will grow to $112.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to an aging population, product and service innovations, economic trends, healthcare policies and regulations, awareness campaigns and marketing, and pandemic impact. Major trends in the forecast period include product innovation for more comprehensive coverage, customizable policies tailored to individual needs, integration with health plans or offered as riders, and advancements in technology influencing coverage options.

The increasing number of cancer cases is expected to drive the growth of the cancer insurance market in the future. This rise is mainly attributed to factors such as aging populations, lifestyle changes such as tobacco use and unhealthy diets, and environmental elements such as pollution and exposure to carcinogens. Cancer insurance offers financial protection by covering medical expenses and other related costs that regular health insurance may not cover, thus helping individuals cope with the substantial financial burdens associated with cancer treatment. For example, according to the International Agency for Research on Cancer (IARC) and the American Cancer Society (ACS), global cancer cases reached nearly 20 million in 2022, with projections indicating a 77% increase to 35 million annually by 2050. Lung cancer was the most prevalent (12.4%), followed by breast (11.6%) and colorectal cancers (9.6%). Lung cancer also accounted for the most deaths, causing 1.8 million fatalities (18.7%), followed by colorectal (9.3%) and liver cancers (7.8%). Therefore, the rising number of cancer cases is expected to boost the growth of the cancer insurance market.

Key players in the cancer insurance market are focusing on developing innovative insurance products, such as specialized cancer insurance policies tailored for women, to offer personalized coverage for their specific healthcare needs. These policies address the unique medical and financial requirements of female policyholders dealing with a cancer diagnosis, providing them with specialized coverage and assistance. For instance, Elephant.in, an India-based insurance company, introduced a unique cancer insurance policy specifically designed for women in March 2024. This policy aims to provide strong financial security to women facing the significant challenges of cancer diagnosis and treatment, covering the five main types of cancers affecting women-breast, cervical, ovarian, oral, and colorectal. It offers lump sum payouts upon diagnosis of any covered cancer, providing financial support ranging from ₹5,00,000 ($0.5 million) to ₹30,00,000 ($0.3 million).

In March 2024, Osara Health, a U.S.-based healthcare solutions provider, collaborated with Allstate Benefit to offer comprehensive cancer support programs to its policyholders. This partnership represents a significant development in the U.S. health insurance market, aiming to improve the overall cancer care experience for individuals battling cancer. Allstate Benefits, a U.S.-based insurance company specializing in cancer insurance policies, is part of this initiative.

Major companies operating in the cancer insurance market are UnitedHealth Group Incorporated, Ping An Insurance (Group) Company of China Ltd, Cigna Group, Allianz SE, Legal & General Group plc, AXA SA, Aetna Inc, MetLife Inc, Dai-ichi Life Holdings Inc, Munich Re Group, China Pacific Life Insurance Co Ltd, American International Group Inc, Liberty Mutual Insurance Company, China Life Insurance Company Limited, Zurich Insurance Group Ltd, MAPFRE SA, Huaxia Life Insurance Co Ltd, Aegon NV, AFLAC Incorporated, Atlas Cancer Insurance Services Ltd, Unum Group, Prudential plc, Bajaj Finserv Limited, Mutual of Omaha Insurance Company, Sun Life Financial Inc, Saga Plc

North America was the largest region in the cancer insurance market in 2024. The regions covered in the cancer insurance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer insurance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer insurance market includes revenues earned by entities by providing services such as lump-sum payments, non-medical expense coverage, support services, and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Insurance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer insurance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer insurance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer insurance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Lung Cancer; Liver Cancer
  • 2) By Insurance Plan: Individual Plan; Supplement Plan; Critical Illness Plan
  • 3) By Distribution Channel: Brokers; Bancassurance; Agents; Direct Sales; Others Distribution Channels
  • 4) By End-user: Adult; Children
  • Subsegments:
  • 1) By Lung Cancer: Smoking-Related Lung Cancer Insurance; Non-Smoking-Related Lung Cancer Insurance; Early-Stage Lung Cancer Insurance; Advanced-Stage Lung Cancer Insurance
  • 2) By Liver Cancer: Hepatitis-Related Liver Cancer Insurance; Non-Viral Liver Cancer Insurance; Early-Stage Liver Cancer Insurance; Advanced-Stage Liver Cancer Insurance
  • Companies Mentioned: UnitedHealth Group Incorporated; Ping An Insurance (Group) Company of China Ltd; Cigna Group; Allianz SE; Legal & General Group plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r29691

Table of Contents

1. Executive Summary

2. Cancer Insurance Market Characteristics

3. Cancer Insurance Market Trends And Strategies

4. Cancer Insurance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cancer Insurance Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cancer Insurance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cancer Insurance Market Growth Rate Analysis
  • 5.4. Global Cancer Insurance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cancer Insurance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cancer Insurance Total Addressable Market (TAM)

6. Cancer Insurance Market Segmentation

  • 6.1. Global Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lung Cancer
  • Liver Cancer
  • 6.2. Global Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Individual Plan
  • Supplement Plan
  • Critical Illness Plan
  • 6.3. Global Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Brokers
  • Bancassurance
  • Agents
  • Direct Sales
  • Others Distribution Channels
  • 6.4. Global Cancer Insurance Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adult
  • Children
  • 6.5. Global Cancer Insurance Market, Sub-Segmentation Of Lung Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Smoking-Related Lung Cancer Insurance
  • Non-Smoking-Related Lung Cancer Insurance
  • Early-Stage Lung Cancer Insurance
  • Advanced-Stage Lung Cancer Insurance
  • 6.6. Global Cancer Insurance Market, Sub-Segmentation Of Liver Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatitis-Related Liver Cancer Insurance
  • Non-Viral Liver Cancer Insurance
  • Early-Stage Liver Cancer Insurance
  • Advanced-Stage Liver Cancer Insurance

7. Cancer Insurance Market Regional And Country Analysis

  • 7.1. Global Cancer Insurance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cancer Insurance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Insurance Market

  • 8.1. Asia-Pacific Cancer Insurance Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Insurance Market

  • 9.1. China Cancer Insurance Market Overview
  • 9.2. China Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Insurance Market

  • 10.1. India Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Insurance Market

  • 11.1. Japan Cancer Insurance Market Overview
  • 11.2. Japan Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Insurance Market

  • 12.1. Australia Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Insurance Market

  • 13.1. Indonesia Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Insurance Market

  • 14.1. South Korea Cancer Insurance Market Overview
  • 14.2. South Korea Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Insurance Market

  • 15.1. Western Europe Cancer Insurance Market Overview
  • 15.2. Western Europe Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Insurance Market

  • 16.1. UK Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Insurance Market

  • 17.1. Germany Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Insurance Market

  • 18.1. France Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Insurance Market

  • 19.1. Italy Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Insurance Market

  • 20.1. Spain Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Insurance Market

  • 21.1. Eastern Europe Cancer Insurance Market Overview
  • 21.2. Eastern Europe Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Insurance Market

  • 22.1. Russia Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Insurance Market

  • 23.1. North America Cancer Insurance Market Overview
  • 23.2. North America Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Insurance Market

  • 24.1. USA Cancer Insurance Market Overview
  • 24.2. USA Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Insurance Market

  • 25.1. Canada Cancer Insurance Market Overview
  • 25.2. Canada Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Insurance Market

  • 26.1. South America Cancer Insurance Market Overview
  • 26.2. South America Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Insurance Market

  • 27.1. Brazil Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Insurance Market

  • 28.1. Middle East Cancer Insurance Market Overview
  • 28.2. Middle East Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Insurance Market

  • 29.1. Africa Cancer Insurance Market Overview
  • 29.2. Africa Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Insurance Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Insurance Market Competitive Landscape
  • 30.2. Cancer Insurance Market Company Profiles
    • 30.2.1. UnitedHealth Group Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Ping An Insurance (Group) Company of China Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Cigna Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Allianz SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Legal & General Group plc Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Insurance Market Other Major And Innovative Companies

  • 31.1. AXA SA
  • 31.2. Aetna Inc
  • 31.3. MetLife Inc
  • 31.4. Dai-ichi Life Holdings Inc
  • 31.5. Munich Re Group
  • 31.6. China Pacific Life Insurance Co Ltd
  • 31.7. American International Group Inc
  • 31.8. Liberty Mutual Insurance Company
  • 31.9. China Life Insurance Company Limited
  • 31.10. Zurich Insurance Group Ltd
  • 31.11. MAPFRE SA
  • 31.12. Huaxia Life Insurance Co Ltd
  • 31.13. Aegon NV
  • 31.14. AFLAC Incorporated
  • 31.15. Atlas Cancer Insurance Services Ltd

32. Global Cancer Insurance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Insurance Market

34. Recent Developments In The Cancer Insurance Market

35. Cancer Insurance Market High Potential Countries, Segments and Strategies

  • 35.1 Cancer Insurance Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cancer Insurance Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cancer Insurance Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!